Selected vitamin D metabolic gene variants and risk for autism spectrum disorder in the CHARGE Study

Rebecca J Schmidt1, Robin L Hansen2, Jaana Hartiala3

  • 1Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA, USA; Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California Davis, Sacramento, CA, USA.

Insights

Paternal and child vitamin D metabolism may influence autism spectrum disorder (ASD) risk. Genetic variations in vitamin D pathways, particularly in fathers, show associations with ASD development.

Area of Science:

  • Genetics
  • Neuroscience
  • Endocrinology

Background:

  • Vitamin D is crucial for neurodevelopment, cognitive, and behavioral functions.
  • Autism spectrum disorder (ASD) is a neurodevelopmental condition with complex etiology.
  • Functional polymorphisms in vitamin D pathways are investigated for their potential role in ASD.

Purpose of the Study:

  • To examine the association between autism spectrum disorder (ASD) and common, functional polymorphisms in vitamin D pathways.
  • To investigate the role of genetic variations in vitamin D metabolism in the etiology of ASD.
  • To analyze the influence of paternal and child vitamin D-related genotypes on ASD risk.

Main Methods:

  • Case-control study (CHARGE) involving children aged 24-60 months with ASD (n=474) and typical development (TD, n=281).
  • Genotyping of vitamin D receptor (VDR) gene polymorphisms (TaqI, BsmI, FokI, Cdx2) and other vitamin D pathway genes (CYP27B1, GC, CYP2R1) in maternal, paternal, and child DNA.
  • Application of case-control logistic regression, family-based log-linear, and hybrid log-linear analyses to assess genetic associations and risk estimates.

Main Results:

  • Paternal VDR TaqI homozygous variant genotype significantly associated with increased ASD risk (OR [CI]: 6.3 [1.9-20.7]).
  • A trend towards increased ASD risk was observed with paternal VDR BsmI genotype (OR [CI]: 4.7 [1.6-13.4]).
  • Child GC AA-genotype/A-allele associated with ASD; child CYP2R1 AA-genotype associated with decreased ASD risk. Parental imprinting effects noted for VDR alleles.

Conclusions:

  • Preliminary evidence suggests paternal and child vitamin D metabolism may contribute to the etiology of ASD.
  • Genetic variations in vitamin D pathways, particularly those inherited paternally, warrant further investigation in ASD.
  • Larger study populations are needed to confirm these findings and explore the role of vitamin D in ASD development.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.9K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
122
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.8K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
110
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.3K